P2X7 and P2Y1 receptors in DRG mediate electroacupuncture to inhibit peripheral sensitization in rats with IBS visceral pain.

Researchers have discovered how electroacupuncture may help relieve abdominal pain in irritable bowel syndrome (IBS) by studying rats with visceral hypersensitivity. IBS affects millions of people worldwide, causing chronic abdominal pain and digestive discomfort that significantly impacts quality of life.

The study focused on specific pain receptors called purinergic receptors located in the dorsal root ganglion (DRG), which are clusters of nerve cells near the spine that process pain signals from internal organs. Scientists induced IBS-like symptoms in rats and then applied electroacupuncture to two specific acupoints: Zusanli (ST36) on the lower leg and Sanyinjiao (SP6) near the ankle—points traditionally used for digestive complaints.

The research revealed that electroacupuncture works through a chain reaction involving three types of receptors: P2X7R, P2Y1R, and P2X3R. In IBS, the P2X7R receptor becomes overactive, triggering pain signals. Electroacupuncture was found to suppress P2X7R activity, which then allowed P2Y1R receptors to increase their pain-relieving effects. This ultimately reduced the activity of P2X3R receptors that directly transmit pain sensations.

What makes this finding significant is that it identifies a specific biological pathway—P2X7R→P2Y1R→P2X3R—through which electroacupuncture reduces peripheral sensitization, meaning it addresses pain hypersensitivity at its source in the nervous system rather than just masking symptoms.

For IBS patients considering acupuncture, this research provides scientific evidence supporting electroacupuncture as a potential treatment option for managing visceral pain. The study suggests that electroacupuncture may offer relief by modulating the nervous system's pain processing mechanisms. Patients interested in electroacupuncture for IBS should seek treatment from a licensed acupuncturist with experience in gastrointestinal disorders.

This rat model study elucidates the molecular mechanisms underlying electroacupuncture-mediated analgesia in IBS visceral hypersensitivity. Researchers induced colonic inflammation using intracolonic TNBS and applied electroacupuncture at ST36 and SP6. Using neural retrograde tracing, neuropharmacology, electrophysiology, and molecular techniques, investigators identified a novel P2X7R→P2Y1R→P2X3R inhibitory pathway in colon-related DRG neurons.

Key findings demonstrate that P2X7R activation promotes visceral pain by upregulating P2X3R, while electroacupuncture inhibits P2X7R activity. Concurrently, electroacupuncture upregulates P2Y1R expression, which exerts analgesic effects by suppressing neuronal P2X3R activity. Satellite glial cells in DRG were implicated in modulating neuronal electrophysiological properties during electroacupuncture treatment.

Clinical implications: This research provides mechanistic evidence for electroacupuncture's efficacy in treating IBS-related visceral pain through peripheral sensitization modulation. The identified purinergic receptor cascade offers potential therapeutic targets and supports the use of ST36 and SP6 for IBS visceral hypersensitivity management. Practitioners should consider electroacupuncture as an evidence-based intervention for patients with functional gastrointestinal disorders presenting with chronic abdominal pain.